In our results, the up-and-down-regulatory functional experiments revealed that SLC2A3 could comprehensively underpin the cancer-promoting aspects in both vivo and vitro, providing a preliminary basis for its cancer-facilitating properties. The gene discussed is SLC2A3; the disease is cancer.